CRH, corticotropin releasing hormone, 1392

N. diseases: 402; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.100 Biomarker phenotype BEFREE The central thesis is that stress leads to changes in corticotropin-releasing factor in the brain that impact addiction. 30227143 2019
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.100 Biomarker phenotype BEFREE Inactivation of a CRF-dependent amygdalofugal pathway reverses addiction-like behaviors in alcohol-dependent rats. 30886240 2019
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.100 Biomarker phenotype BEFREE The corticotropin-releasing factor (CRF) system is a key mediator of the stress response and addictive behavior. 29515519 2018
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.100 Biomarker phenotype BEFREE These findings highlight CRF receptors as potential therapeutic targets to be explored by research about stress-related addiction problems. 29391155 2018
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.100 Biomarker phenotype BEFREE The class B corticotropin-releasing hormone type 1 receptor (CRHR1) is a key player in the stress response whose dysregulation is critically involved in stress-related disorders: psychiatric conditions (i.e. depression, anxiety, and addictions), neuroendocrinological alterations, and neurodegenerative diseases. 30427333 2018
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.100 Biomarker phenotype BEFREE This study assesses the regional expression of the transcripts of the CRF transmission in a nicotine sensitization model, since it is hypothesised that the molecular neuroadaptations that mediate the development of sensitization contribute to the development of addiction. 29857328 2018
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.100 Biomarker phenotype BEFREE Specific contributions about this interaction include the study of CRF receptors in the lateral septum, investigations on the neural mechanisms of cross-sensitization for psychostimulants and ethanol, the identification of the Wnt/β-catenin pathway as a critical neural substrate for stress and addiction, and the emergence of the cannabinoid system as a promising therapeutic target. 30622500 2018
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.100 Biomarker phenotype BEFREE Yet, much remains to be learned about CRF's role in the neurobiology of dysphoria and addiction and the potential for novel anti-CRF therapies therein. 28265716 2017
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.100 Biomarker phenotype BEFREE Corticotropin-releasing factor (CRF) signaling through CRF receptor 1 (CRFR1) regulates autonomic, endocrine and behavioral responses to stress and has been implicated in the pathophysiology of several disorders including anxiety, depression, and addiction. 28823817 2017
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.100 Biomarker phenotype BEFREE Over this time, CRF arguably gained more attention as a target for development of addiction pharmacotherapies. 29056150 2017
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.100 Biomarker phenotype BEFREE In this chapter we focus on behavioral and cellular neuropharmacological studies that have implicated brain stress systems (i.e., corticotropin-releasing factor [CRF]) in the transition to addiction and the predominant brain regions involved. 29056155 2017
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.100 Biomarker phenotype BEFREE CRH is an important integrator of neuroendocrine stress responses in the brain, with a key role in the addiction processes. 28319850 2017
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.100 Biomarker phenotype BEFREE The results of many studies support the influence of the corticotropin-releasing factor (CRF) system on ethanol (EtOH) consumption and EtOH-induced neuroadaptations that are critical in the addiction process. 25565358 2015
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.100 Biomarker phenotype BEFREE In the present review, derived from the 2012 Behavior, Biology and Chemistry "Translational Research in Addiction" symposium, we summarize the anti-relapse potential of corticotropin-releasing factor type 1 (CRF(1)) receptor antagonists to reduce negative emotional symptoms of acute and protracted alcohol withdrawal and stress-induced relapse to alcohol seeking. 23294766 2013